Tissue-specific antibodies against human lung and breast carcinoma dehistonized chromatins.
Tissue-specific antisera against human lung and breast carcinoma dehistonized chromatins were obtained. The specificity of these antisera was determined by complement fixation. In the presence of antiserum against human lung carcinoma, only chromatins from lung carcinoma fixed complement significantly, whereas chromatins isolated from human breast carcinoma, HeLa cells, normal lung tissue, breast tissue, or term placenta were negative (i.e., inactive). In a similar assay with the use of antiserum against dehistonized breast carcinoma chromatins, only breast carcinoma chromatins fixed complement. Immunohistochemical localization of the antigens by the horseradish peroxidase bridge method demonstrated their presence in the nuclei.
D000818:Animals; D000912:Antibodies, Neoplasm; D000918:Antibody Specificity; D000951:Antigens, Neoplasm; D001940:Breast / Q000276:immunology; D001943:Breast Neoplasms / Q000276:immunology*; D006528:Carcinoma, Hepatocellular / Q000276:immunology; D002467:Cell Nucleus / Q000276:immunology; D002642:Chick Embryo; D002843:Chromatin / Q000276:immunology*; D002868:Chromosomal Proteins, Non-Histone / Q000276:immunology; D003168:Complement Fixation Tests; D005260:Female; D006367:HeLa Cells / Q000276:immunology; D006801:Humans; D008113:Liver Neoplasms / Q000276:immunology; D008168:Lung / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental / Q000276:immunology; D009928:Organ Specificity; D010920:Placenta / Q000276:immunology; D011247:Pregnancy
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D002843:Chromatin; D002868:Chromosomal Proteins, Non-Histone